查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1466559

颅内动脉瘤市场：按类型、适应症和最终用户划分 - 全球预测 2024-2030

Intracranial Aneurysm Market by Type (Artery Occlusion & Bypass, Endovascular Coiling, Flow Diverters), Indication (Ruptured Aneurysm, Unruptured Aneurysm), End User - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 186 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计2023年颅内动脉瘤市场规模为13.2亿美元，预计2024年将达16亿美元，2030年将达53.8亿美元，复合年增长率为22.16%。

颅内动脉瘤市场是一个医疗保健产业领域，专注于颅内动脉壁膨出或气球的诊断、治疗和管理。该市场包括各种产品和服务，包括诊断设备、手术器械、药物以及各种治疗选择，包括手术和非手术干预措施。颅内动脉瘤市场的成长受到全球人口老化、高血压和吸烟盛行率增加、医学影像技术进步以及公众对该疾病认识不断提高等因素的影响。此外，医疗基础设施的改善、医疗支出的增加以及微创手术需求的增加也促进了市场的扩张。影响颅内动脉瘤市场成长的限制包括治疗成本高、欠发达和开拓地区医疗设施的使用机会有限以及与侵入性外科手术相关的风险。除此之外，产品核可还存在严格的法律规范，需要能够进行专门介入的熟练专业人员。然而，随着新技术的出现，市场持续成长，包括开拓更有效、侵入性更小的治疗技术、应用人工智慧增强成像和诊断，以及将新型生物材料引入血管内治疗中使用的支架和线圈。我们正在见证一个巨大的潜在机会。此外，基因研究的进步可能会带来更早的检测和个人化的治疗策略。

主要市场统计
基准年[2023] 13.2亿美元
预测年份 [2024] 16亿美元
预测年份 [2030] 53.8亿美元
复合年增长率（%） 22.16%

微创技术的需求，例如小囊状动脉瘤的血管内卷取

动脉闭塞和搭桥手术是当微创治疗方法被认为困难或危险时所使用的一种外科手术。这些手术会关闭受影响的动脉，并使用血管移植物转移血流以维持脑循环。此手术通常用于不适合血管内治疗或先前治疗失败的复杂动脉瘤。血管内卷取是一种微创手术，将导管插入动脉并引导至动脉瘤部位。然后透过导管将软金属线圈放入动脉瘤中，以促进血液凝固并防止血液流入动脉瘤，从而降低破裂的风险。通常选择血管内卷取来治疗许多颅内动脉瘤，因为与开放性手术相比，它的侵入性较小且需要的恢復时间较短。分流器是一种血管内装置，设计用于治疗主动脉瘤和巨大动脉瘤，以及治疗不适合弹簧圈的宽基底动脉瘤。这些类似支架的装置被放置在动脉瘤颈部，以将血流从动脉瘤囊中转移出来。随着时间的推移，这会导致动脉瘤内血栓症，从而导致受影响血管段的重组。分流器可有效闭塞动脉瘤，同时维持载瘤动脉的血流。手术夹闭是颅内动脉瘤的传统且确定的治疗方法，透过开颅手术暴露动脉瘤。然后，神经外科医生在动脉瘤底部放置一个小金属夹，有效地将其与动脉血流隔离。这可以防止动脉瘤生长或破裂。儘管该手术是侵入性的并且需要很长的恢復时间，但它是一种持久的解决方案，具有很高的长期成功率。

最终用户：越来越多的诊所寻求早期筛检和诊断服务的患者数量

诊所，特别是神经科和放射科的诊所，提供颅内动脉瘤的诊断和治疗服务。这些设施通常比医院小，并且往往因其早期诊断、门诊护理和便利性而受到患者的青睐。医院是颅内动脉瘤治疗最全面的最终用途区域，提供全方位的诊断、手术和术后照护。医院通常配备先进的神经影像技术，例如高解析度 MRI 和 CT 扫描仪，这对于动脉瘤治疗的准确诊断和术前规划至关重要。在医院，显微手术夹闭等开放性手术以及弹簧圈和转移等血管内手术均在设备齐全的手术室中进行，手术室配备了训练有素的介入神经放射学放射科医生和神经外科医生。治疗后，医院会提供加护病房来监测患者，特别是在侵入性手术后或出现动脉瘤破裂等併发症时。

区域洞察

在美洲，颅内动脉瘤的盛行率受到遗传、环境和生活型态因素的综合影响。目前正在对医疗基础设施和神经系统疾病（包括颅内动脉瘤）的研究进行大量投资。美国和加拿大拥有先进的医疗保健系统，诊断和治疗率很高，包括外科手术和微创手术。在欧洲、中东和非洲地区，颅内动脉瘤的调查和治疗在欧洲非常活跃，许多国家采用了最新的血管内治疗方法，例如弹簧圈栓塞和血流改道。在中东，随着神经介入设施的可用性增加，医疗保健基础设施也不断发展。然而，由于欧洲、中东和非洲地区社会经济和医疗保健系统的多样性，盛行率和管理实践各不相同。儘管非洲面临卫生资源有限的挑战，但主要都市区仍持续取得进展。在亚太地区，颅内动脉瘤的情况多种多样。日本和韩国等国家技术采用率较高，且注重医疗创新。中国和印度等国家正在迅速发展医疗基础设施，改善神经血管治疗的机会。

FPNV定位矩阵

FPNV定位矩阵对于评估颅内动脉瘤市场至关重要。我们检视与业务策略和产品满意度相关的关键指标，以对供应商进行全面评估。这种深入的分析使用户能够根据自己的要求做出明智的决策。根据评估，供应商被分为四个成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市场占有率分析

市场占有率分析是一种综合工具，可以对颅内动脉瘤市场供应商的现状进行深入而深入的研究。全面比较和分析供应商在整体收益、基本客群和其他关键指标方面的贡献，以便更好地了解公司的绩效及其在争夺市场占有率时面临的挑战。此外，该分析还提供了对该行业竞争特征的宝贵见解，包括在研究基准年观察到的累积、分散主导地位和合併特征等因素。这种详细程度的提高使供应商能够做出更明智的决策并制定有效的策略，从而在市场上获得竞争优势。

该报告对以下几个方面提供了宝贵的见解：

1. 市场渗透率：提供有关主要企业所服务的市场的全面资讯。

2. 市场开拓：我们深入研究利润丰厚的新兴市场，并分析其在成熟细分市场的渗透率。

3. 市场多元化：提供有关新产品发布、开拓地区、最新发展和投资的详细资讯。

4.竞争评估与资讯：对主要企业的市场占有率、策略、产品、认证、监管状况、专利状况、製造能力等进行全面评估。

5. 产品开发与创新：提供对未来技术、研发活动和突破性产品开发的见解。

本报告解决了以下关键问题：

1.颅内动脉瘤市场规模及预测是多少？

2.颅内动脉瘤市场预测期间需要考虑投资的产品、细分市场、应用和领域有哪些？

3.颅内动脉瘤市场的技术趋势和法规结构是什么？

4.颅内动脉瘤市场主要厂商的市场占有率是多少？

5.进入颅内动脉瘤市场合适的型态和策略手段是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 生活型态改变导致脑血管疾病发生率增加
      • 颅内动脉瘤微创治疗趋势
      • 改善颅内动脉瘤的诊断
    • 抑制因素
      • 与治疗相关的副作用和治疗费用上涨
    • 机会
      • 活性化研发活动并推出创新技术产品
      • 血管内弹簧圈栓塞的潜力不断增加
    • 任务
      • 有关手术时机和麻醉诱导的问题
  • 市场区隔分析
    • 类型：对微创技术的需求，例如针对较小囊状动脉瘤的血管内弹簧圈栓塞术
    • 最终用户：寻求早期筛检和诊断服务的诊所之间的患者流量增加
  • 市场趋势分析
  • 俄罗斯-乌克兰衝突的累积影响
  • 高通膨的累积效应
  • 波特五力分析
  • 价值炼和关键路径分析
  • 法规结构分析
  • 客户客製化

第六章颅内动脉瘤市场：依类型

  • 动脉闭塞和搭桥
  • 血管内弹簧圈栓塞
  • 分流器
  • 手术夹闭

第七章颅内动脉瘤市场（按适应症）

  • 动脉瘤破裂
  • 未破裂动脉瘤

第八章颅内动脉瘤市场：依最终用户分类

  • 诊所
  • 医院

第九章 北美及南美颅内动脉瘤市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第10章亚太地区颅内动脉瘤市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章欧洲、中东和非洲的颅内动脉瘤市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • Evasc 宣布临床里程碑并计划与德国子公司扩大欧洲业务
    • OU研究人员设计设备以改善脑动脉瘤的治疗

第13章竞争产品组合

  • 主要企业简介
  • 主要产品系列
Product Code: MRR-A339DAEF9EC7

[186 Pages Report] The Intracranial Aneurysm Market size was estimated at USD 1.32 billion in 2023 and expected to reach USD 1.60 billion in 2024, at a CAGR 22.16% to reach USD 5.38 billion by 2030.

The intracranial aneurysm market is the healthcare industry sector focused on diagnosing, treating, and managing intracranial aneurysms, bulges, or ballooning in the walls of arteries within the cranium. The market includes various products and services such as diagnostic equipment, surgical tools, medications, and a wide range of treatment options, including surgical and non-surgical interventions. Growth in the intracranial aneurysm market is influenced by factors such as the aging global population, the increasing prevalence of hypertension and smoking, advancements in medical imaging technologies, and the rise in public awareness about the condition. Additionally, improvements in healthcare infrastructure, increased healthcare spending, and the growing demand for minimally invasive surgeries contribute to market expansion. Limitations affecting the intracranial aneurysm market growth include high treatment costs, limited access to healthcare facilities in underdeveloped and developing regions, and the risks associated with invasive surgical procedures. Along with these, stringent regulatory frameworks governing product approval and the need for skilled professionals capable of performing specialized interventions. However, the market witnessed new potential opportunities, including developing more effective and less invasive treatment techniques, applying artificial intelligence for enhanced imaging and diagnostics, and introducing novel biomaterials for stents and coils used in endovascular treatments. Furthermore, advancements in genetic research could lead to early detection and personalized treatment strategies.

KEY MARKET STATISTICS
Base Year [2023] USD 1.32 billion
Estimated Year [2024] USD 1.60 billion
Forecast Year [2030] USD 5.38 billion
CAGR (%) 22.16%

Type: Demand for minimally invasive technique such as endovascular coiling for smaller, saccular aneurysms

Artery occlusion and bypass procedures are surgical interventions utilized when an intracranial aneurysm is considered too difficult or dangerous to treat with less invasive methods. These procedures involve closing off the affected artery and rerouting the blood flow using a vessel graft to preserve cerebral circulation. This technique is typically reserved for complex aneurysms that are not amenable to endovascular techniques or where previous treatments have failed. Endovascular coiling is a minimally invasive procedure that implicates inserting a catheter into an artery and navigating it to the aneurysm site. Soft metal coils are then deployed through the catheter into the aneurysm, promoting blood clotting and preventing blood flow into the aneurysm, thus reducing the risk of rupture. Endovascular coiling is often the preferred choice for treating many intracranial aneurysms due to its less invasive nature and reduced recovery time compared to open surgery. Flow diverters are endovascular devices designed to treat large and giant aneurysms and those with a wide base that is not suitable for coiling. These stent-like devices are placed across the neck of the aneurysm to redirect blood flow away from the aneurysm sac. Over time, this leads to thrombosis within the aneurysm and reconstruction of the affected vessel segment. Flow diverters are effective in occluding aneurysms while preserving blood flow in the parent artery. Surgical clipping is a traditional and definitive treatment for intracranial aneurysms that involves a craniotomy to expose the aneurysm. A neurosurgeon then places a small metal clip at the base of the aneurysm, effectively isolating it from the arterial blood flow. This prevents the aneurysm from growing or rupturing. While the procedure is invasive and requires a longer recovery period, it is a durable solution with a high long-term success rate.

End User: Rising patient flow across clinics for early screening and diagnostic services

Clinics, particularly those specializing in neurology and radiology, provide services for diagnosing and treating intracranial aneurysms. These facilities are usually smaller than hospitals and are often preferred by patients for early diagnosis, outpatient care, and convenience. Hospitals represent the most comprehensive end-use segment for intracranial aneurysm management, offering a full spectrum of diagnostic, surgical, and postoperative care. They are typically equipped with advanced neuroimaging technologies, such as high-resolution MRI and CT scanners, essential for the precise diagnosis and preoperative planning of aneurysm treatment. Hospitals facilitate open surgical procedures, such as microsurgical clipping, and endovascular therapies, such as coiling or flow diversion, conducted in well-equipped operating theaters with trained neuro-interventional radiologists and neurosurgeons. Post-treatment, hospitals provide intensive care units for monitoring patients, particularly after invasive surgeries or in the event of complications such as aneurysm rupture.

Regional Insights

In the Americas, the prevalence of intracranial aneurysms is influenced by a combination of genetic, environmental, and lifestyle factors. There is a substantial investment in healthcare infrastructure and research into neurological disorders, including intracranial aneurysms. The U.S. and Canada have advanced healthcare systems with high diagnosis and treatment rates, including surgical interventions and minimally invasive procedures. In the EMEA region, Europe has significant research and management of intracranial aneurysms, with many countries adopting modern endovascular treatments such as coiling and flow diversion. The Middle East has seen growth in healthcare infrastructure with the increasing availability of neurointerventional facilities. However, there are variations in prevalence and management approaches due to diverse socioeconomic and healthcare systems across the EMEA. Africa faces challenges due to limited healthcare resources, but there is ongoing progress in major urban centers. The Asia-Pacific region presents a varied landscape for intracranial aneurysms. Countries including Japan and South Korea have high technological adoption rates and a strong focus on innovation in medical treatments. Countries such as China and India are rapidly developing their healthcare infrastructure, improving access to neurovascular care.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Intracranial Aneurysm Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Intracranial Aneurysm Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Intracranial Aneurysm Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Abbvie Inc., Acandis GmbH, Adeor Medical AG, B. Braun Melsungen AG, Balt Extrusion S.A., Bayer AG, Bristol-Myers Squibb Company, Cardiatis, S.A., Evasc Medical Systems Corp, F. Hoffmann-La Roche AG, Integra Lifesciences Holdings Corporation, Johnson & Johnson Services, Inc., Kaneka Corporation, Medtronic PLC, Merck & Co., Inc., Microport Scientific Corporation, Mizuho Medical Co,Ltd., Oxford Endovascular Ltd., Penumbra, Inc., Pfizer Inc., Stryker Corporation, and Terumo Corporation.

Market Segmentation & Coverage

This research report categorizes the Intracranial Aneurysm Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Type
    • Artery Occlusion & Bypass
    • Endovascular Coiling
    • Flow Diverters
    • Surgical Clipping
  • Indication
    • Ruptured Aneurysm
    • Unruptured Aneurysm
  • End User
    • Clinics
    • Hospitals
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Intracranial Aneurysm Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Intracranial Aneurysm Market?

3. What are the technology trends and regulatory frameworks in the Intracranial Aneurysm Market?

4. What is the market share of the leading vendors in the Intracranial Aneurysm Market?

5. Which modes and strategic moves are suitable for entering the Intracranial Aneurysm Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising Prevalence of Cerebrovascular Disorder due to Changing Lifestyle
      • 5.1.1.2. Inclination for Minimally Invasive Intracranial Aneurysm Procedures
      • 5.1.1.3. Improved Diagnosis for Intracranial Aneurysm
    • 5.1.2. Restraints
      • 5.1.2.1. Side Effects Associated with Therapies and High Cost of Treatments
    • 5.1.3. Opportunities
      • 5.1.3.1. Rise in Research and Development Activities and Introduction of Innovative Technology Products
      • 5.1.3.2. Rising Potential for Endovascular Coiling
    • 5.1.4. Challenges
      • 5.1.4.1. Issues Related to Timing of Surgery and Anesthetic Induction
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Type: Demand for minimally invasive technique such as endovascular coiling for smaller, saccular aneurysms
    • 5.2.2. End User: Rising patient flow across clinics for early screening and diagnostic services
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of Russia-Ukraine Conflict
  • 5.5. Cumulative Impact of High Inflation
  • 5.6. Porter's Five Forces Analysis
    • 5.6.1. Threat of New Entrants
    • 5.6.2. Threat of Substitutes
    • 5.6.3. Bargaining Power of Customers
    • 5.6.4. Bargaining Power of Suppliers
    • 5.6.5. Industry Rivalry
  • 5.7. Value Chain & Critical Path Analysis
  • 5.8. Regulatory Framework Analysis
  • 5.9. Client Customization

6. Intracranial Aneurysm Market, by Type

  • 6.1. Introduction
  • 6.2. Artery Occlusion & Bypass
  • 6.3. Endovascular Coiling
  • 6.4. Flow Diverters
  • 6.5. Surgical Clipping

7. Intracranial Aneurysm Market, by Indication

  • 7.1. Introduction
  • 7.2. Ruptured Aneurysm
  • 7.3. Unruptured Aneurysm

8. Intracranial Aneurysm Market, by End User

  • 8.1. Introduction
  • 8.2. Clinics
  • 8.3. Hospitals

9. Americas Intracranial Aneurysm Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Intracranial Aneurysm Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Intracranial Aneurysm Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. Evasc announces clinical milestones and plans to expand European presence with German subsidiary
    • 12.3.2. OU Researchers Designing Device to Improve Brain Aneurysm Treatment

13. Competitive Portfolio

  • 13.1. Key Company Profiles
  • 13.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. INTRACRANIAL ANEURYSM MARKET RESEARCH PROCESS
  • FIGURE 2. INTRACRANIAL ANEURYSM MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. INTRACRANIAL ANEURYSM MARKET DYNAMICS
  • FIGURE 7. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. AMERICAS INTRACRANIAL ANEURYSM MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 14. AMERICAS INTRACRANIAL ANEURYSM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES INTRACRANIAL ANEURYSM MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 16. UNITED STATES INTRACRANIAL ANEURYSM MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. ASIA-PACIFIC INTRACRANIAL ANEURYSM MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. ASIA-PACIFIC INTRACRANIAL ANEURYSM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA INTRACRANIAL ANEURYSM MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA INTRACRANIAL ANEURYSM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. INTRACRANIAL ANEURYSM MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 22. INTRACRANIAL ANEURYSM MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. INTRACRANIAL ANEURYSM MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY ARTERY OCCLUSION & BYPASS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY ARTERY OCCLUSION & BYPASS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY ENDOVASCULAR COILING, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY ENDOVASCULAR COILING, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY FLOW DIVERTERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY FLOW DIVERTERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY SURGICAL CLIPPING, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY SURGICAL CLIPPING, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY RUPTURED ANEURYSM, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY RUPTURED ANEURYSM, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY UNRUPTURED ANEURYSM, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY UNRUPTURED ANEURYSM, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY CLINICS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY CLINICS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 27. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 28. GLOBAL INTRACRANIAL ANEURYSM MARKET SIZE, BY HOSPITALS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 29. AMERICAS INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 30. AMERICAS INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 31. AMERICAS INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 32. AMERICAS INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 33. AMERICAS INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 34. AMERICAS INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 35. AMERICAS INTRACRANIAL ANEURYSM MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 36. AMERICAS INTRACRANIAL ANEURYSM MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 37. ARGENTINA INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 38. ARGENTINA INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 39. ARGENTINA INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 40. ARGENTINA INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 41. ARGENTINA INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 42. ARGENTINA INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 43. BRAZIL INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 44. BRAZIL INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 45. BRAZIL INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 46. BRAZIL INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 47. BRAZIL INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 48. BRAZIL INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 49. CANADA INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 50. CANADA INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 51. CANADA INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 52. CANADA INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 53. CANADA INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 54. CANADA INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 55. MEXICO INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 56. MEXICO INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 57. MEXICO INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 58. MEXICO INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 59. MEXICO INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 60. MEXICO INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 61. UNITED STATES INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 62. UNITED STATES INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 63. UNITED STATES INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 64. UNITED STATES INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 65. UNITED STATES INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 66. UNITED STATES INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 67. UNITED STATES INTRACRANIAL ANEURYSM MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 68. UNITED STATES INTRACRANIAL ANEURYSM MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 69. ASIA-PACIFIC INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 70. ASIA-PACIFIC INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 71. ASIA-PACIFIC INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 72. ASIA-PACIFIC INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 73. ASIA-PACIFIC INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 74. ASIA-PACIFIC INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 75. ASIA-PACIFIC INTRACRANIAL ANEURYSM MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 76. ASIA-PACIFIC INTRACRANIAL ANEURYSM MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 77. AUSTRALIA INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 78. AUSTRALIA INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 79. AUSTRALIA INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 80. AUSTRALIA INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 81. AUSTRALIA INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 82. AUSTRALIA INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 83. CHINA INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 84. CHINA INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 85. CHINA INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 86. CHINA INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 87. CHINA INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 88. CHINA INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 89. INDIA INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 90. INDIA INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 91. INDIA INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 92. INDIA INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 93. INDIA INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 94. INDIA INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 95. INDONESIA INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 96. INDONESIA INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 97. INDONESIA INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 98. INDONESIA INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 99. INDONESIA INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 100. INDONESIA INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 101. JAPAN INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 102. JAPAN INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 103. JAPAN INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 104. JAPAN INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 105. JAPAN INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 106. JAPAN INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 107. MALAYSIA INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 108. MALAYSIA INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 109. MALAYSIA INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 110. MALAYSIA INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 111. MALAYSIA INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 112. MALAYSIA INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 113. PHILIPPINES INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 114. PHILIPPINES INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 115. PHILIPPINES INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 116. PHILIPPINES INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 117. PHILIPPINES INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 118. PHILIPPINES INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 119. SINGAPORE INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 120. SINGAPORE INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 121. SINGAPORE INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 122. SINGAPORE INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 123. SINGAPORE INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 124. SINGAPORE INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 125. SOUTH KOREA INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 126. SOUTH KOREA INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 127. SOUTH KOREA INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 128. SOUTH KOREA INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 129. SOUTH KOREA INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 130. SOUTH KOREA INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 131. TAIWAN INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 132. TAIWAN INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 133. TAIWAN INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 134. TAIWAN INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 135. TAIWAN INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 136. TAIWAN INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 137. THAILAND INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 138. THAILAND INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 139. THAILAND INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 140. THAILAND INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 141. THAILAND INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 142. THAILAND INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 143. VIETNAM INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 144. VIETNAM INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 145. VIETNAM INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 146. VIETNAM INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 147. VIETNAM INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 148. VIETNAM INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 149. EUROPE, MIDDLE EAST & AFRICA INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 150. EUROPE, MIDDLE EAST & AFRICA INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 151. EUROPE, MIDDLE EAST & AFRICA INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 152. EUROPE, MIDDLE EAST & AFRICA INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 153. EUROPE, MIDDLE EAST & AFRICA INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 154. EUROPE, MIDDLE EAST & AFRICA INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 155. EUROPE, MIDDLE EAST & AFRICA INTRACRANIAL ANEURYSM MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 156. EUROPE, MIDDLE EAST & AFRICA INTRACRANIAL ANEURYSM MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 157. DENMARK INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 158. DENMARK INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 159. DENMARK INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 160. DENMARK INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 161. DENMARK INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 162. DENMARK INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 163. EGYPT INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 164. EGYPT INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 165. EGYPT INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 166. EGYPT INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 167. EGYPT INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 168. EGYPT INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 169. FINLAND INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 170. FINLAND INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 171. FINLAND INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 172. FINLAND INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 173. FINLAND INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 174. FINLAND INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 175. FRANCE INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 176. FRANCE INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 177. FRANCE INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 178. FRANCE INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 179. FRANCE INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 180. FRANCE INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 181. GERMANY INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 182. GERMANY INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 183. GERMANY INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 184. GERMANY INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 185. GERMANY INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 186. GERMANY INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 187. ISRAEL INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 188. ISRAEL INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 189. ISRAEL INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 190. ISRAEL INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 191. ISRAEL INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 192. ISRAEL INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 193. ITALY INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 194. ITALY INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 195. ITALY INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 196. ITALY INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 197. ITALY INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 198. ITALY INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 199. NETHERLANDS INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 200. NETHERLANDS INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 201. NETHERLANDS INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 202. NETHERLANDS INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 203. NETHERLANDS INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 204. NETHERLANDS INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 205. NIGERIA INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 206. NIGERIA INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 207. NIGERIA INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 208. NIGERIA INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 209. NIGERIA INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 210. NIGERIA INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 211. NORWAY INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 212. NORWAY INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 213. NORWAY INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 214. NORWAY INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 215. NORWAY INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 216. NORWAY INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 217. POLAND INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 218. POLAND INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 219. POLAND INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 220. POLAND INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 221. POLAND INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 222. POLAND INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 223. QATAR INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 224. QATAR INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 225. QATAR INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 226. QATAR INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 227. QATAR INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 228. QATAR INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 229. RUSSIA INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 230. RUSSIA INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 231. RUSSIA INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 232. RUSSIA INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 233. RUSSIA INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 234. RUSSIA INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 235. SAUDI ARABIA INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 236. SAUDI ARABIA INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 237. SAUDI ARABIA INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 238. SAUDI ARABIA INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 239. SAUDI ARABIA INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 240. SAUDI ARABIA INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 241. SOUTH AFRICA INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 242. SOUTH AFRICA INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 243. SOUTH AFRICA INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 244. SOUTH AFRICA INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 245. SOUTH AFRICA INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 246. SOUTH AFRICA INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 247. SPAIN INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 248. SPAIN INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 249. SPAIN INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 250. SPAIN INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 251. SPAIN INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 252. SPAIN INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 253. SWEDEN INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 254. SWEDEN INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 255. SWEDEN INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 256. SWEDEN INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 257. SWEDEN INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 258. SWEDEN INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 259. SWITZERLAND INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 260. SWITZERLAND INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 261. SWITZERLAND INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 262. SWITZERLAND INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 263. SWITZERLAND INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 264. SWITZERLAND INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 265. TURKEY INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 266. TURKEY INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 267. TURKEY INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 268. TURKEY INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 269. TURKEY INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 270. TURKEY INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 271. UNITED ARAB EMIRATES INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 272. UNITED ARAB EMIRATES INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 273. UNITED ARAB EMIRATES INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 274. UNITED ARAB EMIRATES INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 275. UNITED ARAB EMIRATES INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 276. UNITED ARAB EMIRATES INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 277. UNITED KINGDOM INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 278. UNITED KINGDOM INTRACRANIAL ANEURYSM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 279. UNITED KINGDOM INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 280. UNITED KINGDOM INTRACRANIAL ANEURYSM MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 281. UNITED KINGDOM INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 282. UNITED KINGDOM INTRACRANIAL ANEURYSM MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 283. INTRACRANIAL ANEURYSM MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 284. INTRACRANIAL ANEURYSM MARKET, FPNV POSITIONING MATRIX, 2023